Abstract: A VGI system includes a plurality of BEVs, a plurality of pieces of EVSE, and a server. The server determines whether the BEV exchanges electric power with a power grid with the use of second EVSE provided in a second area, the second area being different in manner of management of power supply by the power grid from a first area where predetermined first EVSE is provided, the first EVSE being normally used by the BEV. When the server determines that the BEV exchanges electric power with the use of the second EVSE and when the second area is higher than the first area in contribution to DR in exchange of electric power by the BEV, the server grants an incentive higher than in exchange of electric power with the power grid with the use of the first EVSE.

Abstract: An operation management server manages a vehicle equipped with a battery able to store regenerated electric power. The operation management server includes: a processor that generates a message to be transmitted to the vehicle; and a storage that stores traveling histories of a plurality of vehicles. The processor estimates a transition in a power storage amount of the battery on a planned travel route of the vehicle based on a travel plan of the vehicle and the travel histories of the vehicles. The processor generates the message for proposing execution of external power supply from the battery to an outside of the vehicle before the power storage amount reaches a predetermined amount, when an estimation is made that the power storage amount will exceed the predetermined amount on the planned travel route.

Abstract: A server includes an acquisition unit configured to acquire information on power control including at least one of power supply from an electrified vehicle to an electric power system and charge from the electric power system to the electrified vehicle, and a control unit configured to control display during use of an Internet service with a terminal owned by a user of the electrified vehicle. The control unit is configured to, when the electrified vehicle accedes to a request to perform the power control, generate a program command to reduce display of advertisements on the terminal as compared to when the electrified vehicle does not accede to the request to perform the power control.

Abstract: A power management apparatus includes a communication unit (acquisition unit) that acquires information about supply and demand of electric power for a power bank (power storage device), and a processor (controller) that controls electric power received by an electric vehicle from the power bank. The processor sets a power exchange ratio of electric power received from the power bank to electric power supplied to the power bank, depending on the supply and demand of electric power. The processor determines an amount of electric power to be received by the electric vehicle from the power bank, based on an amount of electric power supplied from the electric vehicle to the power bank, and the power exchange ratio.

Abstract: An electrostatic induction generator includes a housing, a first board fixed to the housing, and a second board arranged in parallel to the first board to be able move relative to it, in which electrostatic induction generator, counter electrodes are placed at a first facing surface of the first board, electrically charged films are placed at every other constant interval at a second facing surface of the second board so as to face the counter electrodes, the counter electrodes are comprised of pluralities of first electrodes and second electrodes provided separated from each other at the first facing surface, first electrodes and second electrodes are alternately arranged at constant intervals in a single line, a plurality of lines of single lines of the first electrodes and second electrodes are provided at the first facing surface, and the constant intervals of the plurality of lines respectively differ in phase.

Abstract: Patients with ErbB2-overexpressing cancers can be given an ErbB2 targeting agent as a therapeutic regimen but not all patients are responsive. The present invention concerns the diagnostic, prognostic and therapeutic methods and compositions for evaluating potential efficacy of an ErbB2 targeting agent in ErbB2-overexpressing cancers by evaluating PTEN expression, which is predictive of responsiveness or resistance to ErbB2 targeting agents such as trastuzumab. Low PTEN expression is predictive of a patient who will respond poorly to trastuzumab.

Abstract: Patients with ErbB2-overexpressing cancers can be given an ErbB2 targeting agent as a therapeutic regimen but not all patients are responsive. The present invention concerns the diagnostic, prognostic and therapeutic methods and compositions for evaluating potential efficacy of an ErbB2 targeting agent in an ErbB2-overexpressing cancers by evaluating PTEN expression, which is predictive of responsiveness or resistance to ErbB2 targeting agents such as trastuzumab. Low PTEN expression is predictive of a patient who will respond poorly to trastuzumab.

Abstract: To achieve an effective gas filtering in a plasma spectrometric apparatus using a gas of a comparatively high consumption flow rate, and to improve the analytical ability, there is provided a plasma spectrometric apparatus containing a sample introducer for producing and delivering an injector gas containing an analyte sample, a plasma generator for generating plasma into which the injector gas is introduced, and an analyzer disposed subsequent to the plasma generator for analyzing the analyte sample. The plasma spectrometric apparatus contains a first gas line for supplying gas to the sample introducer, a second gas line for supplying gas to the plasma generator, and a filter located in the first gas line for removing impurities contained in the gas.

Abstract: An electrostatic induction generator includes a housing, a first board fixed to the housing, and a second board arranged in parallel to the first board to be able move relative to it, in which electrostatic induction generator, counter electrodes are placed at a first facing surface of the first board, electrically charged films are placed at every other constant interval at a second facing surface of the second board so as to face the counter electrodes, the counter electrodes are comprised of pluralities of first electrodes and second electrodes provided separated from each other at the first facing surface, first electrodes and second electrodes are alternately arranged at constant intervals in a single line, a plurality of lines of single lines of the first electrodes and second electrodes are provided at the first facing surface, and the constant intervals of the plurality of lines respectively differ in phase.

Abstract: To achieve an effective gas filtering in a plasma spectrometric apparatus using a gas of a comparatively high consumption flow rate, and to improve the analytical ability, there is provided a plasma spectrometric apparatus containing a sample introducer for producing and delivering an injector gas containing an analyte sample, a plasma generator for generating plasma into which the injector gas is introduced, and an analyzer disposed subsequent to the plasma generator for analyzing the analyte sample. The plasma spectrometric apparatus contains a first gas line for supplying gas to the sample introducer, a second gas line for supplying gas to the plasma generator, and a filter located in the first gas line for removing impurities contained in the gas.

Abstract: Provided is a technology capable of preventing arithmetic operation accuracy from deteriorating even when a bipolar transistor used to form a Gilbert multiplier core has poor characteristics. A correction current generating circuit (3) uses a constant current source (301) to feed a constant current I0 to an emitter of a bipolar transistor (Q7) being a first replica transistor having the same current gain ? as bipolar transistors (Q1 to Q4) that form the Gilbert multiplier core (101), to generate a current of ?·I0 on a collector side thereof. The current is output as a correction current ?·I0, and is added to each of one of input signals (±K1·Vy) of the Gilbert multiplier core (101) as a bias current, to thereby eliminate influence of the current gain ? on an output signal being a multiplication result.

Abstract: Patients with ErbB2-overexpressing cancers can be given an ErbB2 targeting agent as a therapeutic regimen but not all patients are responsive. The present invention concerns the diagnostic, prognostic and therapeutic methods and compositions for evaluating potential efficacy of an ErbB2 targeting agent in an ErbB2-overexpressing cancers by evaluating PTEN expression, which is predictive of responsiveness or resistance to ErbB2 targeting agents such as trastuzumab. Low PTEN expression is predictive of a patient who will respond poorly to trastuzumab.

Abstract: Provided is a technology capable of preventing arithmetic operation accuracy from deteriorating even when a bipolar transistor used to form a Gilbert multiplier core has poor characteristics. A correction current generating circuit (3) uses a constant current source (301) to feed a constant current I0 to an emitter of a bipolar transistor (Q7) being a first replica transistor having the same current gain ? as bipolar transistors (Q1 to Q4) that form the Gilbert multiplier core (101), to generate a current of ?·I0 on a collector side thereof. The current is output as a correction current ?·I0, and is added to each of one of input signals (±K1·Vy) of the Gilbert multiplier core (101) as a bias current, to thereby eliminate influence of the current gain ? on an output signal being a multiplication result.

Abstract: The invention is directed to the provision of a physical quantity sensor that can suppress noise caused by external vibrations, while also suppressing variations in output signal caused by variations in reference voltage. The physical quantity sensor includes an oscillator which converts an externally applied physical quantity into an electrical signal, a reference signal generating circuit which outputs a reference signal; an oscillator circuit which causes the oscillator to oscillate by applying an oscillator signal produced based on the reference signal, and a detector circuit which detects an output signal of the oscillator by multiplying the output signal by the oscillator signal and dividing the reference signal.

Abstract: A physical quantity sensor includes a sensor element that converts an externally applied physical quantity to an electrical signal; a detection circuit that amplifies and detects the output signal of this sensor element; and an adjustment circuit that adjusts the output signal from the detection circuit to a predetermined signal by applying the power supply wherein the adjustment circuit comprises an amplifier circuit that amplifies the output signal from the detection circuit and a reference amplifier circuit that has a gain that is made to correspond to the gain of the amplifier circuit. This configuration allows the gain of the amplifier circuit in the adjustment circuit to be varied according to the power supply voltage and, as a results, provides a physical quantity sensor having reliable sensor detection sensitivity and high-accuracy ratiometric characteristics.

Abstract: Patients with ErbB2-overexpressing cancers can be given an ErbB2 targeting agent as a therapeutic regimen but not all patients are responsive. The present invention concerns the diagnostic, prognostic and therapeutic methods and compositions for evaluating potential efficacy of an ErbB2 targeting agent in an ErbB2-overexpressing cancers by evaluating PTEN expression, which is predictive of responsiveness or resistance to ErbB2 targeting agents such as trastuzumab. Low PTEN expression is predictive of a patient who will respond poorly to trastuzumab.

Abstract: A physical quantity sensor 1 comprises a driving circuit 4 that drives a sensor element based on a reference signal; the sensor element 3 that is driven by the driving circuit 4 to convert an externally applied physical quantity to an electrical signal; and an amplifier circuit 5 that amplifies an output signal of the sensor element 3. The driving circuit 4 controls a driving signal, which drives the sensor element, based on the reference signal so that the driving signal is at a fixed level, and the amplifier circuit 5 has a gain characteristic that amplifies the output signal in a direction reverse to a direction in which the reference signal varies or the driving signal of the driving circuit varies. This configuration allows the physical quantity sensor to reduce output level variations in the sensor output against signal level variations in the reference signal and to make the sensitivity constant.

Abstract: A vibration body for angular speed sensor has a vibrator that includes vibration pieces, a supporting part for supporting the vibration pieces, and a mounting substrate for mounting the vibrator. The mounting substrate has a seat part for fixing the supporting part and supporting the vibrator and a base part. The seat part has a level difference representing a predetermined height from the base part. The predetermined height is set larger than an oscillation width of the vibration pieces. The seat part also has an edge portion that has a shape of a curved line, and each line in a direction perpendicular to each position on the edge portion determines a mounting angle for mounting the vibrator and has an angle in the same direction as a reference direction defined in the mounting substrate or in a direction at least one being different from it.

Abstract: Patients with ErbB2-overexpressing cancers can be given an ErbB2 targeting agent as a therapeutic regimen but not all patients are responsive. The present invention concerns the diagnostic, prognostic and therapeutic methods and compositions for evaluating potential efficacy of an ErbB2 targeting agent in an ErbB2-overexpressing cancers by evaluating PTEN expression, which is predictive of responsiveness or resistance to ErbB2 targeting agents such as trastuzumab. Low PTEN expression is predictive of a patient who will respond poorly to trastuzumab.

Abstract: Patients with ErbB2-overexpressing cancers can be given an ErbB2 targeting agent as a therapeutic regimen but not all patients are responsive. The present invention concerns the diagnostic, prognostic and therapeutic methods and compositions for evaluating potential efficacy of an ErbB2 targeting agent in an ErbB2-overexpressing cancers by evaluating PTEN expression, which is predictive of responsiveness or resistance to ErbB2 targeting agents such as trastuzumab. Low PTEN expression is predictive of a patient who will respond poorly to trastuzumab.